Radiological evaluation after treatment of hepatocellular carcinoma: criteria and application

• Main Authors: WANG Wenjun, ZHAO Yan, HAN Guohong
• Format: Article
• Language: zho
• Published: Editorial Department of Journal of Clinical Hepatology 2016-01-01
• Series: Linchuang Gandanbing Zazhi
• Subjects: carcinoma; hepatocellular; response evaluation; diagnostic imaging
• Online Access: http://www.lcgdbzz.org/qk_content.asp?id=7098

An early and accurate response evaluation is essential for clinicians to decide whether to continue the treatment with current therapeutic regimen or to make necessary changes. This article briefly introduces the development of response evaluation criteria for tumors, elaborates on the application of radiological evaluation criteria in local interventional therapy or sorafenib treatment of hepatocellular carcinoma (HCC), compares the four radiological evaluation criteria, i.e., World Health Organization (WHO) criteria, Response Evaluation Criteria in Solid Tumors (RECIST), European Association for the Study of Liver (EASL) criteria, and the modified RECIST (mRECIST), and thinks that EASL criteria and mRECIST are better than WHO criteria and RECIST and can predict the prognosis of HCC patients at earlier time points.